|
시장보고서
상품코드
1807675
세계의 액체생검 시장 규모, 점유율, 동향, 업계 분석 : 시료 유형별, 바이오마커별, 기술별, 용도별, 최종 용도별, 지역별 - 시장 예측(2025-2034년)Liquid Biopsy Market Size, Share, Trends, Industry Analysis Report By Sample Type (Blood Sample, Others), By Biomarker, By Technology, By Application, By End Use, By Region - Market Forecast, 2025-2034 |
||||||
Polaris Market Research의 최신 조사에 따르면 세계의 액체생검 시장 규모는 2034년까지 365억 9,000만 달러에 달할 전망입니다. 이 조사 리포트는 현재 시장 역학의 상세 인사이트와 향후 시장 성장에 관한 분석을 제공하고 있습니다.
액체생검은 혈액이나 소변과 같은 간단한 액체 시료에서 생물학적 마커를 분석하는 첨단 비침습적 진단 검사입니다. 수술이 필요한 기존의 조직 생검과는 달리, 이 방법은 질병에 대한 정보를 보다 안전하고 간편하게 수집할 수 있습니다. 이 방법은 주로 종양에서 혈류로 배출되는 DNA, RNA, 단백질의 미세한 조각을 검출하는 데 중점을 두고 있으며, 종양의 유전자 구성과 시간 경과에 따른 진행을 상세하게 조사할 수 있습니다. 따라서 암의 진단, 모니터링, 치료 계획에 특히 강력한 툴이 될 수 있습니다.
이 시장을 주도하는 것은 특히 전 세계에서 암 환자 수가 증가함에 따라 보다 최소침습적이고 정확한 진단 툴에 대한 요구가 증가하고 있다는 점입니다. 액체생검은 환자의 치료 계획에 정보를 제공하는 특정 유전자 변이를 식별하는 데 도움이 되므로 맞춤형 의료의 추진에도 큰 영향을 미치고 있습니다. 기술이 더욱 정교해지고 가격이 저렴해짐에 따라 액체생검의 용도는 암 생검에 국한되지 않고 생식 건강(생식 의료), 질병 모니터링 등의 분야로 확대되고 있으며, 액체생검 시장 확대에 더욱 박차를 가하고 있습니다.
액체생검 시장 : 분석 개요
샘플 유형별로는 혈액 샘플 부문이 2024년 가장 큰 점유율을 차지했습니다.
바이오마커별로는 순환종양 DNA(ctDNA) 분야가 높은 민감도와 특이도를 바탕으로 가장 큰 점유율을 차지했습니다.
기술별로는 여러 유전자를 한 번에 분석할 수 있는 다유전자 병렬 분석(NGS) 분야가 가장 큰 점유율을 차지하고 있습니다. 또한 고급 암 진단 및 개인별 맞춤 치료 계획에도 일반적으로 사용되고 있습니다.
용도별로는 암 분야가 가장 큰 비중을 차지하고 있습니다. 액체생검은 초기 진단, 가장 효과적인 맞춤 치료법 선택, 치료에 대한 환자 반응 모니터링 등 다양한 용도로 종양학에서 매우 유용하게 활용되고 있습니다.
최종 용도별로는 병원 및 연구소가 가장 큰 비중을 차지하고 있습니다. 이는 병원 및 연구소가 암 진단 및 치료에 널리 활용되고 있으며, 필요한 인프라를 갖추고 있기 때문입니다.
지역별로는 북미가 잘 구축된 의료 시스템과 첨단 진단법의 존재로 인해 2024년 시장에서 가장 큰 점유율을 차지했습니다. 아시아태평양은 빠르게 성장하는 지역 시장 중 하나입니다. 의료비 지출 증가와 의료 인프라 구축에 대한 관심이 높아지면서 이 지역 시장 성장을 촉진하고 있습니다.
액체생검 시장의 주요 기업에는 F. Hoffmann-La Roche Ltd, Illumina, Inc., Guardant Health, Inc., Bio-Rad Laboratories, Inc., Thermo Fisher Scientific, Inc., Natera, Inc., Exact Sciences Corporation, Adaptive Biotechnologies Corporation, Myriad Genetics, Inc., NeoGenomics Laboratories, Inc. 등이 있습니다.
목차
제1장 서론
제2장 개요
제3장 조사 방법
제4장 세계의 액체생검 시장 인사이트
- 주파수 스냅숏
- 액체생검 시장 역학
- 촉진요인과 기회
- 세계 암이환율의 상승
- 맞춤형 의료의 진보
- 억제요인과 과제
- 조기 암 탐지에서 감도의 한계
- 촉진요인과 기회
- PESTEL 분석
- 액체생검 시장의 동향
- 밸류체인 분석
- COVID-19의 영향 분석
제5장 세계의 액체생검 시장 : 시료 유형별
- 주요 분석 결과
- 서론
- 혈액 시료
- 기타
제6장 세계의 액체생검 시장 : 바이오마커별
- 주요 분석 결과
- 서론
- 순환종양세포(CTC)
- 순환 종양 DNA(ctDNA)
- 세포외소포(EV)
- 기타
제7장 세계의 액체생검 시장 : 기술별
- 주요 분석 결과
- 서론
- 복수 유전자 병렬 해석(NGS)
- 단일 유전자 해석(PCR 마이크로어레이)
제8장 세계의 액체생검 시장 : 용도별
- 주요 분석 결과
- 서론
- 암
- 생식건강
- 기타
제9장 세계의 액체생검 시장 : 최종 용도별
- 주요 분석 결과
- 서론
- 병원·검사실
- 전문 클리닉
- 학술연구 센터
- 기타
제10장 세계의 액체생검 시장 : 지역별
- 주요 분석 결과
- 서론
- 액체생검 시장 분석 : 지역별(2020-2034년)
- 북미
- 북미 : 시료 유형별(2020-2034년)
- 북미 : 바이오마커별(2020-2034년)
- 북미 : 기술별(2020-2034년)
- 북미 : 용도별(2020-2034년)
- 북미 : 최종 용도별(2020-2034년)
- 미국
- 캐나다
- 유럽
- 유럽 : 시료 유형별(2020-2034년)
- 유럽 : 바이오마커별(2020-2034년)
- 유럽 : 기술별(2020-2034년)
- 유럽 : 용도별(2020-2034년)
- 유럽 : 최종 용도별(2020-2034년)
- 영국
- 프랑스
- 독일
- 이탈리아
- 스페인
- 네덜란드
- 러시아
- 기타 유럽
- 아시아태평양
- 아시아태평양 : 시료 유형별(2020-2034년)
- 아시아태평양 : 바이오마커별(2020-2034년)
- 아시아태평양 : 기술별(2020-2034년)
- 아시아태평양 : 용도별(2020-2034년)
- 아시아태평양 : 최종 용도별(2020-2034년)
- 중국
- 인도
- 말레이시아
- 일본
- 인도네시아
- 한국
- 호주
- 기타 아시아태평양
- 중동 및 아프리카
- 중동 및 아프리카 : 시료 유형별(2020-2034년)
- 중동 및 아프리카 : 바이오마커별(2020-2034년)
- 중동 및 아프리카 : 기술별(2020-2034년)
- 중동 및 아프리카 : 용도별(2020-2034년)
- 중동 및 아프리카 : 최종 용도별(2020-2034년)
- 사우디아라비아
- 아랍에미리트
- 이스라엘
- 남아프리카공화국
- 기타 중동 및 아프리카
- 라틴아메리카
- 라틴아메리카 : 시료 유형별(2020-2034년)
- 라틴아메리카 : 바이오마커별(2020-2034년)
- 라틴아메리카 : 기술별(2020-2034년)
- 라틴아메리카 : 용도별(2020-2034년)
- 라틴아메리카 : 최종 용도별(2020-2034년)
- 멕시코
- 브라질
- 아르헨티나
- 기타 라틴아메리카
제11장 경쟁 구도
- 확대와 인수 분석
- 확대
- 인수
- 제휴/협업/합의/공개
제12장 기업 개요
- Adaptive Biotechnologies Corporation
- Bio-Rad Laboratories, Inc.
- Exact Sciences Corporation
- F. Hoffmann-La Roche Ltd
- Guardant Health, Inc.
- Illumina, Inc.
- Myriad Genetics, Inc.
- Natera, Inc.
- NeoGenomics Laboratories, Inc.
- Thermo Fisher Scientific, Inc.
The global liquid biopsy market size is expected to reach USD 36.59 billion by 2034, according to a new study by Polaris Market Research. The report "Liquid Biopsy Market Size, Share, Trends, Industry Analysis Report By Sample Type (Blood Sample, Others), By Biomarker, By Technology, By Application, By End Use, By Region - Market Forecast, 2025-2034" gives a detailed insight into current market dynamics and provides analysis on future market growth.
A liquid biopsy is an advanced, noninvasive diagnostic test that analyzes biological markers from a simple fluid sample, such as blood or urine. Unlike a traditional tissue biopsy, which requires a surgical procedure, this method allows for a safer and more convenient way to gather information about a disease. It primarily focuses on detecting tiny fragments of DNA, RNA, and proteins shed by tumors into the bloodstream, offering doctors a detailed look at a tumor's genetic makeup and progression over time. This makes it an especially powerful tool for cancer diagnosis, monitoring, and treatment planning.
The market is driven by the growing need for less invasive and more accurate diagnostic tools, especially with the rising number of cancer cases worldwide. The push for personalized medicine has also been a major influence, as liquid biopsies can help identify specific genetic mutations that inform a patient's treatment plan. As technologies become more refined and affordable, the application of liquid biopsies is expanding beyond cancer biopsy into areas such as reproductive health and disease monitoring, further fueling the liquid biopsy market expansion.
Liquid Biopsy Market Report Highlights
Based on sample type, the blood sample segment held the largest share in 2024, owing to its convenience and the wide range of biomarkers it provides.
In terms of biomarker, the circulating tumor DNA (ctDNA) segment held the largest share because of its high sensitivity and specificity.
By technology, the multi-gene parallel analysis (NGS) segment held the largest share due to its ability to analyze multiple genes at once. It is also commonly used for advanced cancer diagnostics and personalized treatment planning.
By application, the cancer segment held the largest share. Liquid biopsies are highly valuable in oncology for a wide range of uses, including initial diagnosis, selecting the most effective personalized therapies, and monitoring a patient's response to treatment..
By end use, the hospitals and laboratories segment held the largest share because they are widely utilized for cancer diagnosis and treatment, and have the necessary infrastructure.
By region, North America held the largest share in 2024 in the market due to its well-established healthcare system and presence of advanced diagnostics. Asia Pacific is one of the fastest-growing regional markets. Increasing healthcare spending and a growing focus on improving medical infrastructure are propelling the market growth in the region.
A few key players in the liquid biopsy market include F. Hoffmann-La Roche Ltd; Illumina, Inc.; Guardant Health, Inc.; Bio-Rad Laboratories, Inc.; Thermo Fisher Scientific, Inc.; Natera, Inc.; Exact Sciences Corporation; Adaptive Biotechnologies Corporation; Myriad Genetics, Inc.; and NeoGenomics Laboratories, Inc.
Polaris Market Research has segmented the liquid biopsy market report based on sample type, biomarker, technology, application, end use, and region:
By Sample Type Outlook (Revenue - USD Billion, 2020-2034)
Blood Sample
Others
By Biomarker Outlook (Revenue - USD Billion, 2020-2034)
Circulating Tumor Cells (CTCs)
Circulating Tumor DNA (ctDNA)
Extracellular Vehicles (EVs)
Others
By Technology Outlook (Revenue - USD Billion, 2020-2034)
Multi-gene parallel Analysis (NGS)
Single Gene Analysis (PCR Microarrays)
By Application Outlook (Revenue - USD Billion, 2020-2034)
Cancer
Reproductive Health
Others
By End Use Outlook (Revenue - USD Billion, 2020-2034)
Hospitals and Laboratories
Specialty Clinics
Academic and Research Centers
Others
By Regional Outlook (Revenue - USD Billion, 2020-2034)
North America
U.S.
Canada
Europe
Germany
France
UK
Italy
Spain
Netherlands
Russia
Rest of Europe
Asia Pacific
China
Japan
India
Malaysia
South Korea
Indonesia
Australia
Vietnam
Rest of Asia Pacific
Middle East & Africa
Saudi Arabia
UAE
Israel
South Africa
Rest of Middle East & Africa
Latin America
Mexico
Brazil
Argentina
Rest of Latin America
Table of Contents
1. Introduction
- 1.1. Report Description
- 1.1.1. Objectives of the Study
- 1.1.2. Market Scope
- 1.1.3. Assumptions
- 1.2. Stakeholders
2. Executive Summary
- 2.1. Market Highlights
3. Research Methodology
- 3.1. Overview
- 3.1.1. Data Mining
- 3.2. Data Sources
- 3.2.1. Primary Sources
- 3.2.2. Secondary Sources
4. Global Liquid Biopsy Market Insights
- 4.1. Liquid Biopsy Market - Frequency Snapshot
- 4.2. Liquid Biopsy Market Dynamics
- 4.2.1. Drivers and Opportunities
- 4.2.1.1. Rising Global Cancer Incidence
- 4.2.1.2. Advancements in Personalized Medicine
- 4.2.2. Restraints and Challenges
- 4.2.2.1. Limited sensitivity in early-stage cancer detection
- 4.2.1. Drivers and Opportunities
- 4.3. Porter's Five Forces Analysis
- 4.3.1. Bargaining Power of Suppliers (Moderate)
- 4.3.2. Threats of New Entrants: (Low)
- 4.3.3. Bargaining Power of Buyers (Moderate)
- 4.3.4. Threat of Substitute (Moderate)
- 4.3.5. Rivalry among existing firms (High)
- 4.4. PESTEL Analysis
- 4.5. Liquid Biopsy Market Trends
- 4.6. Value Chain Analysis
- 4.7. COVID-19 Impact Analysis
5. Global Liquid Biopsy Market, by Sample Type
- 5.1. Key Findings
- 5.2. Introduction
- 5.2.1. Global Liquid Biopsy Market, by Sample Type, 2020-2034 (USD Billion)
- 5.3. Blood Sample
- 5.3.1. Global Liquid Biopsy Market, Blood Sample, by Region, 2020-2034 (USD Billion)
- 5.4. Others
- 5.4.1. Global Liquid Biopsy Market, Others, by Region, 2020-2034 (USD Billion)
6. Global Liquid Biopsy Market, by Biomarker
- 6.1. Key Findings
- 6.2. Introduction
- 6.2.1. Global Liquid Biopsy Market, by Biomarker, 2020-2034 (USD Billion)
- 6.3. Circulating Tumor Cells (CTCs)
- 6.3.1. Global Liquid Biopsy Market, by Circulating Tumor Cells (CTCs), by Region, 2020-2034 (USD Billion)
- 6.4. Circulating Tumor DNA (ctDNA)
- 6.4.1. Global Liquid Biopsy Market, by Circulating Tumor DNA (ctDNA), by Region, 2020-2034 (USD Billion)
- 6.5. Extracellular Vehicles (EVs)
- 6.5.1. Global Liquid Biopsy Market, by Extracellular Vehicles (EVs), by Region, 2020-2034 (USD Billion)
- 6.6. Others
- 6.6.1. Global Liquid Biopsy Market, by Others, by Region, 2020-2034 (USD Billion)
7. Global Liquid Biopsy Market, by Technology
- 7.1. Key Findings
- 7.2. Introduction
- 7.2.1. Global Liquid Biopsy Market, by Technology, 2020-2034 (USD Billion)
- 7.3. Multi-gene parallel Analysis (NGS)
- 7.3.1. Global Liquid Biopsy Market, by Multi-gene parallel Analysis (NGS), by Region, 2020-2034 (USD Billion)
- 7.4. Single Gene Analysis (PCR Microarrays)
- 7.4.1. Global Liquid Biopsy Market, by Single Gene Analysis (PCR Microarrays), by Region, 2020-2034 (USD Billion)
8. Global Liquid Biopsy Market, by Application
- 8.1. Key Findings
- 8.2. Introduction
- 8.2.1. Global Liquid Biopsy Market, by Application, 2020-2034 (USD Billion)
- 8.3. Cancer
- 8.3.1. Global Liquid Biopsy Market, by Cancer, by Region, 2020-2034 (USD Billion)
- 8.4. Reproductive health
- 8.4.1. Global Liquid Biopsy Market, by Reproductive health, by Region, 2020-2034 (USD Billion)
- 8.5. Others
- 8.5.1. Global Liquid Biopsy Market, by Others, by Region, 2020-2034 (USD Billion)
9. Global Liquid Biopsy Market, by End Use
- 9.1. Key Findings
- 9.2. Introduction
- 9.2.1. Global Liquid Biopsy Market, by End Use, 2020-2034 (USD Billion)
- 9.3. Hospitals and Laboratories
- 9.3.1. Global Liquid Biopsy Market, by Hospitals and Laboratories, by Region, 2020-2034 (USD Billion)
- 9.4. Specialty Clinics
- 9.4.1. Global Liquid Biopsy Market, by Specialty Clinics, by Region, 2020-2034 (USD Billion)
- 9.5. Academic and Research Centers
- 9.5.1. Global Liquid Biopsy Market, by Academic and Research Centers, by Region, 2020-2034 (USD Billion)
- 9.6. Others
- 9.6.1. Global Liquid Biopsy Market, by Others, by Region, 2020-2034 (USD Billion)
10. Global Liquid Biopsy Market, by Geography
- 10.1. Key Findings
- 10.2. Introduction
- 10.2.1. Liquid Biopsy Market Assessment, By Geography, 2020-2034 (USD Billion)
- 10.3. Liquid Biopsy Market - North America
- 10.3.1. North America: Liquid Biopsy Market, by Sample Type, 2020-2034 (USD Billion)
- 10.3.2. North America: Liquid Biopsy Market, by Biomarker, 2020-2034 (USD Billion)
- 10.3.3. North America: Liquid Biopsy Market, by Technology, 2020-2034 (USD Billion)
- 10.3.4. North America: Liquid Biopsy Market, by Application, 2020-2034 (USD Billion)
- 10.3.5. North America: Liquid Biopsy Market, by End Use, 2020-2034 (USD Billion)
- 10.3.6. North America: Sample Type
- 10.3.7. Liquid Biopsy Market - U.S.
- 10.3.7.1. U.S.: Liquid Biopsy Market, by Sample Type, 2020-2034 (USD Billion)
- 10.3.7.2. U.S.: Liquid Biopsy Market, by Biomarker, 2020-2034 (USD Billion)
- 10.3.7.3. U.S.: Liquid Biopsy Market, by Technology, 2020-2034 (USD Billion)
- 10.3.7.4. U.S.: Liquid Biopsy Market, by Application, 2020-2034 (USD Billion)
- 10.3.7.5. U.S.: Liquid Biopsy Market, by End Use, 2020-2034 (USD Billion)
- 10.3.8. Liquid Biopsy Market - Canada
- 10.3.8.1. Canada: Liquid Biopsy Market, by Sample Type, 2020-2034 (USD Billion)
- 10.3.8.2. Canada: Liquid Biopsy Market, by Biomarker, 2020-2034 (USD Billion)
- 10.3.8.3. Canada: Liquid Biopsy Market, by Technology, 2020-2034 (USD Billion)
- 10.3.8.4. Canada: Liquid Biopsy Market, by Application, 2020-2034 (USD Billion)
- 10.3.8.5. Canada: Liquid Biopsy Market, by End Use, 2020-2034 (USD Billion)
- 10.4. Liquid Biopsy Market - Europe
- 10.4.1. Europe: Liquid Biopsy Market, by Sample Type, 2020-2034 (USD Billion)
- 10.4.2. Europe: Liquid Biopsy Market, by Biomarker, 2020-2034 (USD Billion)
- 10.4.3. Europe: Liquid Biopsy Market, by Technology, 2020-2034 (USD Billion)
- 10.4.4. Europe: Liquid Biopsy Market, by Application, 2020-2034 (USD Billion)
- 10.4.5. Europe: Liquid Biopsy Market, by End Use, 2020-2034 (USD Billion)
- 10.4.6. Liquid Biopsy Market - UK
- 10.4.6.1. UK: Liquid Biopsy Market, by Sample Type, 2020-2034 (USD Billion)
- 10.4.6.2. UK: Liquid Biopsy Market, by Biomarker, 2020-2034 (USD Billion)
- 10.4.6.3. UK: Liquid Biopsy Market, by Technology, 2020-2034 (USD Billion)
- 10.4.6.4. UK: Liquid Biopsy Market, by Application, 2020-2034 (USD Billion)
- 10.4.6.5. UK: Liquid Biopsy Market, by End Use, 2020-2034 (USD Billion)
- 10.4.7. Liquid Biopsy Market - France
- 10.4.7.1. France: Liquid Biopsy Market, by Sample Type, 2020-2034 (USD Billion)
- 10.4.7.2. France: Liquid Biopsy Market, by Biomarker, 2020-2034 (USD Billion)
- 10.4.7.3. France: Liquid Biopsy Market, by Technology, 2020-2034 (USD Billion)
- 10.4.7.4. France: Liquid Biopsy Market, by Application, 2020-2034 (USD Billion)
- 10.4.7.5. France: Liquid Biopsy Market, by End Use, 2020-2034 (USD Billion)
- 10.4.8. Liquid Biopsy Market - Germany
- 10.4.8.1. Germany: Liquid Biopsy Market, by Sample Type, 2020-2034 (USD Billion)
- 10.4.8.2. Germany: Liquid Biopsy Market, by Biomarker, 2020-2034 (USD Billion)
- 10.4.8.3. Germany: Liquid Biopsy Market, by Technology, 2020-2034 (USD Billion)
- 10.4.8.4. Germany: Liquid Biopsy Market, by Application, 2020-2034 (USD Billion)
- 10.4.8.5. Germany: Liquid Biopsy Market, by End Use, 2020-2034 (USD Billion)
- 10.4.9. Liquid Biopsy Market - Italy
- 10.4.9.1. Italy: Liquid Biopsy Market, by Sample Type, 2020-2034 (USD Billion)
- 10.4.9.2. Italy: Liquid Biopsy Market, by Biomarker, 2020-2034 (USD Billion)
- 10.4.9.3. Italy: Liquid Biopsy Market, by Technology, 2020-2034 (USD Billion)
- 10.4.9.4. Italy: Liquid Biopsy Market, by Application, 2020-2034 (USD Billion)
- 10.4.9.5. Italy: Liquid Biopsy Market, by End Use, 2020-2034 (USD Billion)
- 10.4.10. Liquid Biopsy Market - Spain
- 10.4.10.1. Spain: Liquid Biopsy Market, by Sample Type, 2020-2034 (USD Billion)
- 10.4.10.2. Spain: Liquid Biopsy Market, by Biomarker, 2020-2034 (USD Billion)
- 10.4.10.3. Spain: Liquid Biopsy Market, by Technology, 2020-2034 (USD Billion)
- 10.4.10.4. Spain: Liquid Biopsy Market, by Application, 2020-2034 (USD Billion)
- 10.4.10.5. Spain: Liquid Biopsy Market, by End Use, 2020-2034 (USD Billion)
- 10.4.11. Liquid Biopsy Market - Netherlands
- 10.4.11.1. Netherlands: Liquid Biopsy Market, by Sample Type, 2020-2034 (USD Billion)
- 10.4.11.2. Netherlands: Liquid Biopsy Market, by Biomarker, 2020-2034 (USD Billion)
- 10.4.11.3. Netherlands: Liquid Biopsy Market, by Technology, 2020-2034 (USD Billion)
- 10.4.11.4. Netherlands: Liquid Biopsy Market, by Application, 2020-2034 (USD Billion)
- 10.4.11.5. Netherlands: Liquid Biopsy Market, by End Use, 2020-2034 (USD Billion)
- 10.4.12. Liquid Biopsy Market - Russia
- 10.4.12.1. Russia: Liquid Biopsy Market, by Sample Type, 2020-2034 (USD Billion)
- 10.4.12.2. Russia: Liquid Biopsy Market, by Biomarker, 2020-2034 (USD Billion)
- 10.4.12.3. Russia: Liquid Biopsy Market, by Technology, 2020-2034 (USD Billion)
- 10.4.12.4. Russia: Liquid Biopsy Market, by Application, 2020-2034 (USD Billion)
- 10.4.12.5. Russia: Liquid Biopsy Market, by End Use, 2020-2034 (USD Billion)
- 10.4.13. Liquid Biopsy Market - Rest of Europe
- 10.4.13.1. Rest of Europe: Liquid Biopsy Market, by Sample Type, 2020-2034 (USD Billion)
- 10.4.13.2. Rest of Europe: Liquid Biopsy Market, by Biomarker, 2020-2034 (USD Billion)
- 10.4.13.3. Rest of Europe: Liquid Biopsy Market, by Technology, 2020-2034 (USD Billion)
- 10.4.13.4. Rest of Europe: Liquid Biopsy Market, by Application, 2020-2034 (USD Billion)
- 10.4.13.5. Rest of Europe: Liquid Biopsy Market, by End Use, 2020-2034 (USD Billion)
- 10.5. Liquid Biopsy Market - Asia Pacific
- 10.5.1. Asia Pacific: Liquid Biopsy Market, by Sample Type, 2020-2034 (USD Billion)
- 10.5.2. Asia Pacific: Liquid Biopsy Market, by Biomarker, 2020-2034 (USD Billion)
- 10.5.3. Asia Pacific: Liquid Biopsy Market, by Technology, 2020-2034 (USD Billion)
- 10.5.4. Asia Pacific: Liquid Biopsy Market, by Application, 2020-2034 (USD Billion)
- 10.5.5. Asia Pacific: Liquid Biopsy Market, by End Use, 2020-2034 (USD Billion)
- 10.5.6. Liquid Biopsy Market - China
- 10.5.6.1. China: Liquid Biopsy Market, by Sample Type, 2020-2034 (USD Billion)
- 10.5.6.2. China: Liquid Biopsy Market, by Biomarker, 2020-2034 (USD Billion)
- 10.5.6.3. China: Liquid Biopsy Market, by Technology, 2020-2034 (USD Billion)
- 10.5.6.4. China: Liquid Biopsy Market, by Application, 2020-2034 (USD Billion)
- 10.5.6.5. China: Liquid Biopsy Market, by End Use, 2020-2034 (USD Billion)
- 10.5.7. Liquid Biopsy Market - India
- 10.5.7.1. India: Liquid Biopsy Market, by Sample Type, 2020-2034 (USD Billion)
- 10.5.7.2. India: Liquid Biopsy Market, by Biomarker, 2020-2034 (USD Billion)
- 10.5.7.3. India: Liquid Biopsy Market, by Technology, 2020-2034 (USD Billion)
- 10.5.7.4. India: Liquid Biopsy Market, by Application, 2020-2034 (USD Billion)
- 10.5.7.5. India: Liquid Biopsy Market, by End Use, 2020-2034 (USD Billion)
- 10.5.8. Liquid Biopsy Market - Malaysia
- 10.5.8.1. Malaysia: Liquid Biopsy Market, by Sample Type, 2020-2034 (USD Billion)
- 10.5.8.2. Malaysia: Liquid Biopsy Market, by Biomarker, 2020-2034 (USD Billion)
- 10.5.8.3. Malaysia: Liquid Biopsy Market, by Technology, 2020-2034 (USD Billion)
- 10.5.8.4. Malaysia: Liquid Biopsy Market, by Application, 2020-2034 (USD Billion)
- 10.5.8.5. Malaysia: Liquid Biopsy Market, by End Use, 2020-2034 (USD Billion)
- 10.5.9. Liquid Biopsy Market - Japan
- 10.5.9.1. Japan: Liquid Biopsy Market, by Sample Type, 2020-2034 (USD Billion)
- 10.5.9.2. Japan: Liquid Biopsy Market, by Biomarker, 2020-2034 (USD Billion)
- 10.5.9.3. Japan: Liquid Biopsy Market, by Technology, 2020-2034 (USD Billion)
- 10.5.9.4. Japan: Liquid Biopsy Market, by Application, 2020-2034 (USD Billion)
- 10.5.9.5. Japan: Liquid Biopsy Market, by End Use, 2020-2034 (USD Billion)
- 10.5.10. Liquid Biopsy Market - Indonesia
- 10.5.10.1. Indonesia: Liquid Biopsy Market, by Sample Type, 2020-2034 (USD Billion)
- 10.5.10.2. Indonesia: Liquid Biopsy Market, by Biomarker, 2020-2034 (USD Billion)
- 10.5.10.3. Indonesia: Liquid Biopsy Market, by Technology, 2020-2034 (USD Billion)
- 10.5.10.4. Indonesia: Liquid Biopsy Market, by Application, 2020-2034 (USD Billion)
- 10.5.10.5. Indonesia: Liquid Biopsy Market, by End Use, 2020-2034 (USD Billion)
- 10.5.11. Liquid Biopsy Market - South Korea
- 10.5.11.1. South Korea: Liquid Biopsy Market, by Sample Type, 2020-2034 (USD Billion)
- 10.5.11.2. South Korea: Liquid Biopsy Market, by Biomarker, 2020-2034 (USD Billion)
- 10.5.11.3. South Korea: Liquid Biopsy Market, by Technology, 2020-2034 (USD Billion)
- 10.5.11.4. South Korea: Liquid Biopsy Market, by Application, 2020-2034 (USD Billion)
- 10.5.11.5. South Korea: Liquid Biopsy Market, by End Use, 2020-2034 (USD Billion)
- 10.5.12. Liquid Biopsy Market - Australia
- 10.5.12.1. Australia: Liquid Biopsy Market, by Sample Type, 2020-2034 (USD Billion)
- 10.5.12.2. Australia: Liquid Biopsy Market, by Biomarker, 2020-2034 (USD Billion)
- 10.5.12.3. Australia: Liquid Biopsy Market, by Technology, 2020-2034 (USD Billion)
- 10.5.12.4. Australia: Liquid Biopsy Market, by Application, 2020-2034 (USD Billion)
- 10.5.12.5. Australia: Liquid Biopsy Market, by End Use, 2020-2034 (USD Billion)
- 10.5.13. Liquid Biopsy Market - Rest of Asia Pacific
- 10.5.13.1. Rest of Asia Pacific: Liquid Biopsy Market, by Sample Type, 2020-2034 (USD Billion)
- 10.5.13.2. Rest of Asia Pacific: Liquid Biopsy Market, by Biomarker, 2020-2034 (USD Billion)
- 10.5.13.3. Rest of Asia Pacific: Liquid Biopsy Market, by Technology, 2020-2034 (USD Billion)
- 10.5.13.4. Rest of Asia Pacific: Liquid Biopsy Market, by Application, 2020-2034 (USD Billion)
- 10.5.13.5. Rest of Asia Pacific: Liquid Biopsy Market, by End Use, 2020-2034 (USD Billion)
- 10.6. Liquid Biopsy Market - Middle East & Africa
- 10.6.1. Middle East & Africa: Liquid Biopsy Market, by Sample Type, 2020-2034 (USD Billion)
- 10.6.2. Middle East & Africa: Liquid Biopsy Market, by Biomarker, 2020-2034 (USD Billion)
- 10.6.3. Middle East & Africa: Liquid Biopsy Market, by Technology, 2020-2034 (USD Billion)
- 10.6.4. Middle East & Africa: Liquid Biopsy Market, by Application, 2020-2034 (USD Billion)
- 10.6.5. Middle East & Africa: Liquid Biopsy Market, by End Use, 2020-2034 (USD Billion)
- 10.6.6. Liquid Biopsy Market - Saudi Arabia
- 10.6.6.1. Saudi Arabia: Liquid Biopsy Market, by Sample Type, 2020-2034 (USD Billion)
- 10.6.6.2. Saudi Arabia: Liquid Biopsy Market, by Biomarker, 2020-2034 (USD Billion)
- 10.6.6.3. Saudi Arabia: Liquid Biopsy Market, by Technology, 2020-2034 (USD Billion)
- 10.6.6.4. Saudi Arabia: Liquid Biopsy Market, by Application, 2020-2034 (USD Billion)
- 10.6.6.5. Saudi Arabia: Liquid Biopsy Market, by End Use, 2020-2034 (USD Billion)
- 10.6.7. Liquid Biopsy Market - UAE
- 10.6.7.1. UAE: Liquid Biopsy Market, by Sample Type, 2020-2034 (USD Billion)
- 10.6.7.2. UAE: Liquid Biopsy Market, by Biomarker, 2020-2034 (USD Billion)
- 10.6.7.3. UAE: Liquid Biopsy Market, by Technology, 2020-2034 (USD Billion)
- 10.6.7.4. UAE: Liquid Biopsy Market, by Application, 2020-2034 (USD Billion)
- 10.6.7.5. UAE: Liquid Biopsy Market, by End Use, 2020-2034 (USD Billion)
- 10.6.8. Liquid Biopsy Market - Israel
- 10.6.8.1. Israel: Liquid Biopsy Market, by Sample Type, 2020-2034 (USD Billion)
- 10.6.8.2. Israel: Liquid Biopsy Market, by Biomarker, 2020-2034 (USD Billion)
- 10.6.8.3. Israel: Liquid Biopsy Market, by Technology, 2020-2034 (USD Billion)
- 10.6.8.4. Israel: Liquid Biopsy Market, by Application, 2020-2034 (USD Billion)
- 10.6.8.5. Israel: Liquid Biopsy Market, by End Use, 2020-2034 (USD Billion)
- 10.6.9. Liquid Biopsy Market - South Africa
- 10.6.9.1. South Africa: Liquid Biopsy Market, by Sample Type, 2020-2034 (USD Billion)
- 10.6.9.2. South Africa: Liquid Biopsy Market, by Biomarker, 2020-2034 (USD Billion)
- 10.6.9.3. South Africa: Liquid Biopsy Market, by Technology, 2020-2034 (USD Billion)
- 10.6.9.4. South Africa: Liquid Biopsy Market, by Application, 2020-2034 (USD Billion)
- 10.6.9.5. South Africa: Liquid Biopsy Market, by End Use, 2020-2034 (USD Billion)
- 10.6.10. Liquid Biopsy Market - Rest of Middle East & Africa
- 10.6.10.1. Rest of Middle East & Africa: Liquid Biopsy Market, by Sample Type, 2020-2034 (USD Billion)
- 10.6.10.2. Rest of Middle East & Africa: Liquid Biopsy Market, by Biomarker, 2020-2034 (USD Billion)
- 10.6.10.3. Rest of Middle East & Africa: Liquid Biopsy Market, by Technology, 2020-2034 (USD Billion)
- 10.6.10.4. Rest of Middle East & Africa: Liquid Biopsy Market, by Application, 2020-2034 (USD Billion)
- 10.6.10.5. Rest of Middle East & Africa: Liquid Biopsy Market, by End Use, 2020-2034 (USD Billion)
- 10.7. Liquid Biopsy Market - Latin America
- 10.7.1. Latin America: Liquid Biopsy Market, by Sample Type, 2020-2034 (USD Billion)
- 10.7.2. Latin America: Liquid Biopsy Market, by Biomarker, 2020-2034 (USD Billion)
- 10.7.3. Latin America: Liquid Biopsy Market, by Technology, 2020-2034 (USD Billion)
- 10.7.4. Latin America: Liquid Biopsy Market, by Application, 2020-2034 (USD Billion)
- 10.7.5. Latin America: Liquid Biopsy Market, by End Use, 2020-2034 (USD Billion)
- 10.7.6. Liquid Biopsy Market - Mexico
- 10.7.6.1. Mexico: Liquid Biopsy Market, by Sample Type, 2020-2034 (USD Billion)
- 10.7.6.2. Mexico: Liquid Biopsy Market, by Biomarker, 2020-2034 (USD Billion)
- 10.7.6.3. Mexico: Liquid Biopsy Market, by Technology, 2020-2034 (USD Billion)
- 10.7.6.4. Mexico: Liquid Biopsy Market, by Application, 2020-2034 (USD Billion)
- 10.7.6.5. Mexico: Liquid Biopsy Market, by End Use, 2020-2034 (USD Billion)
- 10.7.7. Liquid Biopsy Market - Brazil
- 10.7.7.1. Brazil: Liquid Biopsy Market, by Sample Type, 2020-2034 (USD Billion)
- 10.7.7.2. Brazil: Liquid Biopsy Market, by Biomarker, 2020-2034 (USD Billion)
- 10.7.7.3. Brazil: Liquid Biopsy Market, by Technology, 2020-2034 (USD Billion)
- 10.7.7.4. Brazil: Liquid Biopsy Market, by Application, 2020-2034 (USD Billion)
- 10.7.7.5. Brazil: Liquid Biopsy Market, by End Use, 2020-2034 (USD Billion)
- 10.7.8. Liquid Biopsy Market - Argentina
- 10.7.8.1. Argentina: Liquid Biopsy Market, by Sample Type, 2020-2034 (USD Billion)
- 10.7.8.2. Argentina: Liquid Biopsy Market, by Biomarker, 2020-2034 (USD Billion)
- 10.7.8.3. Argentina: Liquid Biopsy Market, by Technology, 2020-2034 (USD Billion)
- 10.7.8.4. Argentina: Liquid Biopsy Market, by Application, 2020-2034 (USD Billion)
- 10.7.8.5. Argentina: Liquid Biopsy Market, by End Use, 2020-2034 (USD Billion)
- 10.7.9. Liquid Biopsy Market - Rest of Latin America
- 10.7.9.1. Rest of Latin America: Liquid Biopsy Market, by Sample Type, 2020-2034 (USD Billion)
- 10.7.9.2. Rest of Latin America: Liquid Biopsy Market, by Biomarker, 2020-2034 (USD Billion)
- 10.7.9.3. Rest of Latin America: Liquid Biopsy Market, by Technology, 2020-2034 (USD Billion)
- 10.7.9.4. Rest of Latin America: Liquid Biopsy Market, by Application, 2020-2034 (USD Billion)
- 10.7.9.5. Rest of Latin America: Liquid Biopsy Market, by End Use, 2020-2034 (USD Billion)
11. Competitive Landscape
- 11.1. Expansion and Acquisition Analysis
- 11.1.1. Expansion
- 11.1.2. Acquisitions
- 11.2. Partnerships/Collaborations/Agreements/Exhibitions
12. Company Profiles
- 12.1. Adaptive Biotechnologies Corporation
- 12.1.1. Company Overview
- 12.1.2. Financial Performance
- 12.1.3. Product Benchmarking
- 12.1.4. Recent Development
- 12.2. Bio-Rad Laboratories, Inc.
- 12.2.1. Company Overview
- 12.2.2. Financial Performance
- 12.2.3. Product Benchmarking
- 12.2.4. Recent Development
- 12.3. Exact Sciences Corporation
- 12.3.1. Company Overview
- 12.3.2. Financial Performance
- 12.3.3. Product Benchmarking
- 12.3.4. Recent Development
- 12.4. F. Hoffmann-La Roche Ltd
- 12.4.1. Company Overview
- 12.4.2. Financial Performance
- 12.4.3. Product Benchmarking
- 12.4.4. Recent Development
- 12.5. Guardant Health, Inc.
- 12.5.1. Company Overview
- 12.5.2. Financial Performance
- 12.5.3. Product Benchmarking
- 12.5.4. Recent Development
- 12.6. Illumina, Inc.
- 12.6.1. Company Overview
- 12.6.2. Financial Performance
- 12.6.3. Product Benchmarking
- 12.6.4. Recent Development
- 12.7. Myriad Genetics, Inc.
- 12.7.1. Company Overview
- 12.7.2. Financial Performance
- 12.7.3. Product Benchmarking
- 12.7.4. Recent Development
- 12.8. Natera, Inc.
- 12.8.1. Company Overview
- 12.8.2. Financial Performance
- 12.8.3. Product Benchmarking
- 12.8.4. Recent Development
- 12.9. NeoGenomics Laboratories, Inc.
- 12.9.1. Company Overview
- 12.9.2. Financial Performance
- 12.9.3. Product Benchmarking
- 12.9.4. Recent Development
- 12.10. Thermo Fisher Scientific, Inc.
- 12.10.1. Company Overview
- 12.10.2. Financial Performance
- 12.10.3. Product Benchmarking
- 12.10.4. Recent Development
